Are beta‐blockers on the therapeutic horizon for ovarian cancer treatment?

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|19|3380-3383

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.19, 2015-10, pp. : 3380-3383

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical impact of selective and nonselective beta‐blockers on survival in patients with ovarian cancer

By  

CANCER, Vol. 121, Iss. 19, 2015-10 ,pp. : 3444-3451

John Wiley & Sons Inc

Access to resources Recommend Favorite

Beta-blockers in Children with Duchenne Cardiomyopathy

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 2, 2014-06 ,pp. : 76-81

Bentham Science Publishers

Access to resources Recommend Favorite

Beta-Blockers in Pediatric Hypertrophic Cardiomyopathies

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 2, 2014-06 ,pp. : 82-85

Bentham Science Publishers

Access to resources Recommend Favorite

Beta-Blockers in Acute Coronary Syndrome

By  

Cardiology, Vol. 115, Iss. 3, 2009-12 ,pp. : 170-171

Karger

Access to resources Recommend Favorite

Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials

By Monami Matteo   Filippi Luca   Ungar Andrea   Sgrilli Federica   Antenore Alessandro   Dicembrini Ilaria   Bagnoli Paola   Marchionni Niccolò   Rotella Carlo Maria   Mannucci Edoardo  

Current Medical Research and Opinion, Vol. 29, Iss. 4, 2013-04 ,pp. : 369-378

Informa Healthcare

Access to resources Recommend Favorite